InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:

PROGEN PHARMACEUTICALS LIMITED (PGL)
(This company subsequently changed its name to TBG DIAGNOSTICS LIMITED. You should refer to that name for Status.)

Date of Listing:

22 December 1995

Subsequent Names:

Company Name	Start Date	End Date
TBG DIAGNOSTICS LIMITED	02/02/2016

Former Names:

Stock Exchange Status: (updated daily)

This company subsequently changed its name to TBG DIAGNOSTICS LIMITED. You should refer to that name for Stock Exchange Status.

Legal Status: (updated monthly)

This company subsequently changed its name to TBG DIAGNOSTICS LIMITED. You should refer to that name for Legal Status.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This company subsequently changed its name and is now TBG DIAGNOSTICS LIMITED. You should refer to that name for Capital Gains Tax Status.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

PROGEN PHARMACEUTICALS LIMITED(PGL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
PROGEN PHARMACEUTICALS LIMITED	02/04/2007	02/02/2016
PROGEN INDUSTRIES LIMITED		02/04/2007

Shareholder links

Our website ranking of PGL:

(5 out of 5)

COMPANY WEBSITE:

PGL website

PGL email

PGL investorRelations

PGL announcements

PGL annualreports

PGL directors

REGISTRY:

Level 1, 200 Mary Street Brisbane QLD 4000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail

Company details

Address: Level 18, 101 Collins Street Melbourne VIC 3000
Tel: +61-7-3273 9133 Fax: +61-7-3375 1168

Date first listed: 22/12/1995
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Research & development of potential biopharmaceutical therapeutics for the treatement of human diseases; development, manufacture, importation & distribution of a range of molecular biology products, consumables & fine chemicals for the scientific researc

News & Events

Expand this box to read and print

name changed to TBG Diagnostics Limited	02/02/2016
The company provides the following update: the company is working towards a relisting date of 3 February, 2016; the company has completed the acquisition of TBG Inc.; it has received valid applications for a total of 60,579,000 new shares which represents a total raising of $12,721,590 which were issued to investors pursuant to the terms of the offer under the prospectus; company will change its ASX code; and it has also provided an indicative timetable.	29/01/2016
TBG Diagnostics Limited (formerly Progen Pharmaceuticals Ltd) advises that the following unlisted options issued under the Company's Employee Share Option Plan have lapsed: Number: 90,000 Exercise Price: $0.29 Expiry: 1 January 2016	29/01/2016
The company is pleased to announce that the Company has received valid applications for a total of 69,579,000 new shares under the Prospectus dated 10 November 2015, which represents a total raising of $12,721,590.	11/12/2015
The securities of Progen Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, following receipt of security holder approval concerning a transaction which will result in a significant change to the Company's scale. The Company's securities will remain suspended until the Company has complied with Chapters 1 and 2 of the Listing Rules in accordance with Listing Rule 11.1.3. Security Code: PGL	07/12/2015
name changed from Progen Industries Limited	02/04/2007

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
14/05/2014	Jitto Arulampalam	40,000	$1.010	$40,398.00
12/03/2014	Heng Tang	10,000	$0.520	$5,200.00
12/12/2013	Heng Tang	10,000	$0.220	$2,196.00
06/12/2013	Heng Tang	33,000	$0.227	$7,475.00
26/03/2013	Woei-Jia Jiang	13,389	$0.230	$3,079.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Jitto Arulampalam	Non Exec Chairman	12/06/2013
Emily Lee	Director	07/12/2015
Eugene Cheng	Director	07/12/2015
Stanley Chang	Director	07/12/2015
Blair Lucas	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.